A5077914139- Hair Growth and Disorders
- Dermatologic Treatments and Research
- Autoimmune Bullous Skin Diseases
- RNA regulation and disease
- Chronic Myeloid Leukemia Treatments
- Dermatology and Skin Diseases
Schweiger Dermatology Group (United States)
2022
Hudson Dermatology
2021-2022
The current classification for alopecia areata (AA) does not provide a consistent assessment of disease severity.To develop an AA severity scale based on expert experience.A modified Delphi process was utilized. An advisory group 22 clinical experts from the United States formed to this scale. Representatives pharmaceutical industry provided feedback during its development.Survey responses were used draft criteria, aspiring simple that may be easily applied in practice. A consensus vote held...
Although alopecia areata (AA) severity is often defined by the degree of scalp hair loss, its impact on QOL can also be a defining measure severity. In this cross-sectional study (AA Disease Specific Program), 259 patients were surveyed for demographics, AA illness characteristics, (Skindex-16 AA), and daily impairment (Work Productivity Activity Impairment). The association between patient demographics variables, Skindex-16 scores, Work Impairment scores analyzed using regression analyses....